Doses of fluticasone propionate inhalation powder 50 and 100 mcg twice daily significantly improved FEV1 (15% and 18% change from baseline at Endpoint, respectively) compared with placebo (7% change).
Objective: To evaluate the efficacy and tolerability of two inhaled corticosteroid treatment regimens, fluticasone propionate (FP) delivered from a Diskus TM inhaler and budesonide delivered from ...
The abbreviated new drug application (ANDA) for the fluticasone propionate and salmeterol inhalation powder – named VR 315 – will see Vectura receive $10 million for its part in the drug's ...
Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide ... twice daily from a Diskus™ inhaler for a 4-week run-in period ...
Hosted on MSN1mon
Environmentally Friendlier COPD Inhaler May Also Be More EffectiveThe other single-inhaler on the market for COPD triple therapy, fluticasone-umeclidinium-vilanterol, is a dry-powder inhaler that does not contain hydrofluoroalkane-134a. In a 2024 JAMA report ...
A small proportion of veterans who went from a metered-dose inhaler to a dry-powder inhaler had to revert to the metered-dose inhaler, according to a research letter published in JAMA Network ...
Hosted on MSN1mon
Study Compares Single-Inhaler Triple Therapies for Treatment of COPDa twice-daily metered dose inhaler, and fluticasone-umeclidinium-vilanterol, a once-daily dry powder inhaler for treatment of COPD in routine clinical practice in a new-user, 1:1 propensity score ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback